The forefront of ovarian cancer therapy: update on PARP inhibitors
Mirza, M.R., Coleman, R.L., González-Martín, A., Moore, K.N., Colombo, N., Ray-Coquard, I., Pignata, S.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
Phase III, randomized trial of mirvetuximab soravtansine versus chemotherapy in patients with platinum-resistant ovarian cancer: primary analysis of FORWARD I
Moore, K.N., Oza, A.M., Colombo, N., Oaknin, A., Scambia, G., Lorusso, D., Konecny, G.E., Banerjee, S., Murphy, C.G., Tanyi, J.L., Hirte, H., Konner, J.A., Lim, P.C., Prasad-Hayes, M., Monk, B.J., Pautier, P., Wang, J., Berkenblit, A., Vergote, I., Birrer, M.J.
Published in Annals of oncology (01.06.2021)
Published in Annals of oncology (01.06.2021)
Get full text
Journal Article
Treatment of patients with recurrent epithelial ovarian cancer for whom platinum is still an option
Buechel, M., Herzog, T.J., Westin, S.N., Coleman, R.L., Monk, B.J., Moore, K.N.
Published in Annals of oncology (01.05.2019)
Published in Annals of oncology (01.05.2019)
Get full text
Journal Article
Adding immunotherapy to first-line treatment of advanced and metastatic endometrial cancer
Bogani, G., Monk, B.J., Powell, M.A., Westin, S.N., Slomovitz, B., Moore, K.N., Eskander, R.N., Raspagliesi, F., Barretina-Ginesta, M.-P., Colombo, N., Mirza, M.R.
Published in Annals of oncology (01.05.2024)
Published in Annals of oncology (01.05.2024)
Get full text
Journal Article
PARP inhibitors and newly second primary malignancies in cancer patients: a systematic review and safety meta-analysis of placebo randomized controlled trials
Morice, P.-M., Ray-Coquard, I., Moore, K.N., Diéras, V., Alexandre, J.
Published in Annals of oncology (01.08.2021)
Published in Annals of oncology (01.08.2021)
Get full text
Journal Article
Anti-NaPi2b antibody–drug conjugate lifastuzumab vedotin (DNIB0600A) compared with pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer in a randomized, open-label, phase II study
Banerjee, S., Oza, A.M., Birrer, M.J., Hamilton, E.P., Hasan, J., Leary, A., Moore, K.N., Mackowiak-Matejczyk, B., Pikiel, J., Ray-Coquard, I., Trask, P., Lin, K., Schuth, E., Vaze, A., Choi, Y., Marsters, J.C., Maslyar, D.J., Lemahieu, V., Wang, Y., Humke, E.W., Liu, J.F.
Published in Annals of oncology (01.04.2018)
Published in Annals of oncology (01.04.2018)
Get full text
Journal Article
Phase I study of safety and pharmacokinetics of the anti-MUC16 antibody–drug conjugate DMUC5754A in patients with platinum-resistant ovarian cancer or unresectable pancreatic cancer
Liu, J.F., Moore, K.N., Birrer, M.J., Berlin, S., Matulonis, U.A., Infante, J.R., Wolpin, B., Poon, K.A., Firestein, R., Xu, J., Kahn, R., Wang, Y., Wood, K., Darbonne, W.C., Lackner, M.R., Kelley, S.K., Lu, X., Choi, Y.J., Maslyar, D., Humke, E.W., Burris, H.A.
Published in Annals of oncology (01.11.2016)
Published in Annals of oncology (01.11.2016)
Get full text
Journal Article
Inclusion, diversity, equity, and access (IDEA) in gynecologic cancer clinical trials: A joint statement from GOG foundation and Society of Gynecologic Oncology (SGO)
Pothuri, B., Blank, S.V., Myers, T.K., Hines, J.F., Randall, L.M., O'Cearbhaill, R.E., Slomovitz, B.M., Eskander, R.N., Alvarez Secord, A., Coleman, R.L., Walker, J.L., Monk, B.J., Moore, K.N., O'Malley, D.M., Copeland, L.J., Herzog, T.J.
Published in Gynecologic oncology (01.07.2023)
Published in Gynecologic oncology (01.07.2023)
Get full text
Journal Article
Phase I study of the checkpoint kinase 1 inhibitor GDC-0575 in combination with gemcitabine in patients with refractory solid tumors
Italiano, A., Infante, J.R., Shapiro, G.I., Moore, K.N., LoRusso, P.M., Hamilton, E., Cousin, S., Toulmonde, M., Postel-Vinay, S., Tolaney, S., Blackwood, E.M., Mahrus, S., Peale, F.V., Lu, X., Moein, A., Epler, J., DuPree, K., Tagen, M., Murray, E.R., Schutzman, J.L., Lauchle, J.O., Hollebecque, A., Soria, J.-C.
Published in Annals of oncology (01.05.2018)
Published in Annals of oncology (01.05.2018)
Get full text
Journal Article
A phase II trial of bevacizumab and rucaparib in recurrent carcinoma of the cervix or endometrium
Jackson, C.G., Moore, K.N., Cantrell, L., Erickson, B.K., Duska, L.R., Richardson, D.L., Landrum, L.M., Holman, L.L., Walker, J.L., Mannel, R.S., Moxley, K.M., Queimado, L., Cohoon, A., Ding, K., Dockery, L.E.
Published in Gynecologic oncology (01.07.2022)
Published in Gynecologic oncology (01.07.2022)
Get full text
Journal Article
A randomized phase II evaluation of weekly gemcitabine plus pazopanib versus weekly gemcitabine alone in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma
Duska, L.R., Petroni, G.R., Varhegyi, N., Brown, J., Jelovac, D., Moore, K.N., McGuire, W.P., Darus, C., Barroilhet, L.M., Secord, A.A.
Published in Gynecologic oncology (01.06.2020)
Published in Gynecologic oncology (01.06.2020)
Get full text
Journal Article
A phase Ib/II and pharmacokinetic study of EP0057 (formerly CRLX101) in combination with weekly paclitaxel in patients with recurrent or persistent epithelial ovarian, fallopian tube, or primary peritoneal cancer
Duska, L.R., Krasner, C.N., O'Malley, D.M., Hays, J.L., Modesitt, S.C., Mathews, C.A., Moore, K.N., Thaker, P.H., Miller, A., Purdy, C., Zamboni, W.C., Lucas, A.T., Supko, J.G., Schilder, R.J.
Published in Gynecologic oncology (01.03.2021)
Published in Gynecologic oncology (01.03.2021)
Get full text
Journal Article
Fifth Ovarian Cancer Consensus Conference: individualized therapy and patient factors
McGee, J., Bookman, M., Harter, P., Marth, C., McNeish, I., Moore, K.N., Poveda, A., Hilpert, F., Hasegawa, K., Bacon, M., Gatsonis, C., Brand, A., Kridelka, F., Berek, J., Ottevanger, N., Levy, T., Silverberg, S., Kim, B.-G., Hirte, H., Okamoto, A., Stuart, G., Ochiai, K.
Published in Annals of oncology (01.04.2017)
Published in Annals of oncology (01.04.2017)
Get full text
Journal Article
Conference Proceeding
Web Resource
Measurements of adiposity as prognostic biomarkers for survival with anti-angiogenic treatment in epithelial ovarian cancer: An NRG Oncology/Gynecologic Oncology Group ancillary data analysis of GOG 218
Wade, K.N. Slaughter, Brady, M.F., Thai, T., Wang, Y., Zheng, B., Salani, R., Tewari, K.S., Gray, H.J., Bakkum-Gamez, J.N., Burger, R.A., Moore, K.N., Bookman, M.A.
Published in Gynecologic oncology (01.10.2019)
Published in Gynecologic oncology (01.10.2019)
Get full text
Journal Article